MELISSA ENNIS: Open Payments
NPI 1548989650 · HEMET, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $107 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $141 |
| Janssen Biotech, Inc. | 3 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $69 |
| UROGEN PHARMA, INC. | 1 | $31 |
| Boston Scientific Corporation | 1 | $28 |
| PFIZER INC. | 1 | $27 |
| Endo USA, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| IMMUNITYBIO, INC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: LUPRON DEPOT, ERLEADA, Nubeqa, SpyGlass Discover, XTANDI, AVEED, BOTOX, ADSTILADRIN.
Industry payments across CA — which companies pay providers there.
